Cyclacel Pharmaceuticals Inc
NASDAQ:CYCC 3:59:53 PM EDT
Earnings Announcements
Cyclacel Pharmaceuticals Reports First Quarter 2022 Results
Published: 05/11/2022 20:47 GMT
Cyclacel Pharmaceuticals Inc (CYCC) - Cyclacel Pharmaceuticals Reports First Quarter 2022 Financial Results and Provides Business Update.
Cyclacel Pharmaceuticals Inc - Cash Runway Through Mid-2023.
Cyclacel Pharmaceuticals Inc Qtrly Net Loss per Share - Basic and Diluted $0.42.
Cyclacel Pharmaceuticals Inc - Cash Runway Through Mid-2023.
Cyclacel Pharmaceuticals Inc Qtrly Net Loss per Share - Basic and Diluted $0.42.
Revenue is expected to be $0 Million
Adjusted EPS is expected to be -$0.54
Next Quarter Revenue Guidance is expected to be $0 Million
Next Quarter EPS Guidance is expected to be -$0.55
More details on our Analysts Page.
Adjusted EPS is expected to be -$0.54
Next Quarter Revenue Guidance is expected to be $0 Million
Next Quarter EPS Guidance is expected to be -$0.55
More details on our Analysts Page.